Cardialen: Cardialen Awarded $3 Million Federal Grant
NIH funding will be used to develop the company's implantable, low-energy therapy designed to treat atrial fibrillation.
Read full article »
Cardialen is a Minnesota-based medical device company that develops implantable cardioversion and defibrillation products for the treatment of atrial fibrillation.
Read more